Skip to main content

SigmaGraft Biomaterials

Advancing Healing.Enhancing Lives.

SigmaGraft develops and manufactures next-generation biomaterials that support natural healing and improve patient outcomes.

Our Products Partner With Us
  • Evidence-Based Solutions

    Products backed by science and clinical evidence.

  • Innovation Driven

    Continuous research and development for what's next.

  • Quality & Safety First

    Manufactured to the highest standards for patient safety.

  • Community Impact

    Honoring the gift of donation and giving hope to patients.

  • Trusted Partnerships

    Building strong relationships to deliver greater impact.

OUR PRODUCTS

Biomaterials Designed for Regeneration

Our portfolio includes allograft and xenograft solutions that are safe, effective, and easy to use.

View All Products
  • Allografts

    Human donor-derived biomaterials that support natural tissue regeneration by providing a biologically compatible scaffold for healing.

  • Xenografts

    Animal-derived biomaterials, typically processed from bovine or porcine sources, designed to provide long-lasting structural support for tissue regeneration.

  • Bioceramics

    Synthetic calcium phosphate-based biomaterials that closely resemble natural bone mineral to promote bone growth and integration.

  • Natural polymers

    Biologically derived materials, such as collagen, gelatin, or hyaluronic acid, that support cell attachment, tissue repair, and regenerative healing.

BY APPLICATIONS

Solutions for Every Site of Care

Our biomaterials are designed to support healing across a range of clinical applications.

  • Dental

    Bone grafts and membranes for implant placement, ridge augmentation, and sinus lift procedures.

    Learn More
  • Orthopedic

    Biomaterials for spinal fusion, trauma, and reconstructive orthopedic applications.

    Learn More
  • Wound Care

    Advanced matrices and membranes to support tissue regeneration and wound healing.

    Learn More
SCIENCE & INNOVATION

Rooted in Science.
Focused on the Future.

We invest in research, clinical studies, and advanced manufacturing to develop biomaterials that set new standards in regenerative medicine.

Learn More
  • 20 +

    Years of Combined Experience

    Deep expertise in tissue science and biomaterials.

  • 10 +

    Clinical Studies

    Published results supporting safety and effectiveness.

  • 30 +

    Countries Reached

    Delivering trusted solutions to surgeons worldwide.

QUALITY & COMPLIANCE

Built on Quality.
Backed by Compliance.

SigmaGraft is committed to the highest global standards to ensure product safety, quality, and traceability.

Our Standards
  • FDA Registered
    Facility
  • MDSAP
    Certified
  • ISO 13485:2016
    Certified
  • 21 CFR 1271
    Compliant

Let's Build Better Outcomes— Together.

We collaborate with surgeons, distributors, and healthcare partners to bring innovative solutions to more patients.

JOB INQUIRY

Get in touch

Submit your inquiry to info@sigmagraft.com about a job opportunity or submit your resume.

Elcin Chang is the Executive Vice President of SigmaGraft Biomaterials, where he oversees the research and development of next-generation biomaterials, the manufacture of high-quality medical devices, and the company’s private-label business segment.

Elcin Chang joined SigmaGraft in 2019, initially working in legal and regulatory affairs before becoming involved in nearly every aspect of the business, from research and development to manufacturing. He graduated from the University of San Diego with a degree in political science and joined the U.S. Army Reserve after college. He later earned both a law degree and an M.B.A. from the University of Maryland.

Outside of work, Elcin enjoys traveling and playing sports. He is deeply committed to his work, family, church, and community.